Replies to post #30923 on Nexus Energy Services Inc (IBGR)

[surfguy]

All Howard was generally interested in was outright lying to shareholders in PR's, two of which I know enticed heavy share purchasing. He should have been shut down by the SEC a long time ago. Unfortunately the SEC doesn't have the resources to investigate two-bit penny ventures like Pharmstar.

[BeenLiedTo]

HOWARD claims a meeting to try to overturn this decision is going to happen.
He FAILED to say when it was...
But in his email yesterday he says it is so..
Based on his past promises and lack of truth in his statements I will believe it when I see it.

Have meeting setup in Washington with patent examiner and her supervisor, who totally misunderstands the concept. Very respected patent attorney in the pharmaceutical field is totally confident patent will be granted including a new one that we are getting ready to file for a more advanced concept. Better buy stock now. You will soon see.

Howard Phykitt
President, CEO

PharmStar Pharmaceuticals, Inc.

Phone: [phone]
Direct: 919 794 7001
Cell: 919 633 7000
Fax: [phone]
Web. www.pharmstarinc.com
Web. www.aquaprin.com

[Beck808]

rsteel asked if a patent is required on the Aquaprin product

See PHAR’s May 2011 IP valuation, page 9 -

This total present value of $32 million is determined to be the value of the intellectual property rights associated with the Aquaprin™ product and the Insta-prin™ applicator product, since in the absence of the intellectual property applicable to these products, commercialization would not be viable, and there would be no barrier to entry to far larger competitors with correspondingly larger resources. The exclusionary rights associated with the proprietary patent position of PSP, together with the branding trademarks, and substantial know-how of Howard Phykitt, provide a reasonable basis for such valuation.


[url]http://www.otcmarkets.com/financialReportViewer?symbol=PHAR&id=50096
[/url][tag]IP valuation filed at OTC Markets[/tag]